Literature DB >> 29518228

NLRP3 Inflammasome Activation Mediates Zika Virus-Associated Inflammation.

Zhenjian He1,2, Jiahui Chen3,2, Xun Zhu3,2, Shu An3,2, Xinhuai Dong3,2, Jianchen Yu3,2, Shihao Zhang4, Yun Wu3,2, Ge Li5, Yu Zhang5, Jueheng Wu3,2, Mengfeng Li3,2.   

Abstract

Zika virus (ZIKV) is a mosquito-borne virus that has been identified as a cause of several severe disease manifestations, including congenital microcephaly and Guillain-Barré syndrome, meningoencephalitis, and myelitis. Previous studies showed that ZIKV-infected patients exhibited elevated plasma levels of interleukin 1β (IL-1β), indicating that ZIKV may activate inflammasomes. However, the molecular basis for its viral pathogenesis remains poorly understood. In this current study, we found that ZIKV infection caused severe inflammatory pathological changes and promoted IL-1β production in vitro and in vivo. We here demonstrate that the maturation and secretion of IL-1β during ZIKV infection was mediated by NLRP3 inflammasome activation and that ZIKV nonstructural protein 5 (NS5) facilitated the assembly of the NLRP3 inflammasome complex, leading to IL-1β activation through interaction with NLRP3 and induction of reactive oxygen species production. Collectively, our data identify NLRP3 inflammasome-derived IL-1β production as a critical feature of inflammation during ZIKV infection. These findings offer new insights into inflammasome-mediated diseases and may provide new therapeutic options for ZIKV-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29518228     DOI: 10.1093/infdis/jiy129

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection.

Authors:  Peter Halfmann; Lindsay Hill-Batorski; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

2.  Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.

Authors:  Blandine Monel; Maaran Michael Rajah; Mohamed Lamine Hafirassou; Samy Sid Ahmed; Julien Burlaud-Gaillard; Peng-Peng Zhu; Quentin Nevers; Julian Buchrieser; Françoise Porrot; Cécile Meunier; Sonia Amraoui; Maxime Chazal; Audrey Salles; Nolwenn Jouvenet; Philippe Roingeard; Craig Blackstone; Ali Amara; Olivier Schwartz
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

3.  Pyroptosis in Antiviral Immunity.

Authors:  Teneema Kuriakose; Thirumala-Devi Kanneganti
Journal:  Curr Top Microbiol Immunol       Date:  2019-12-25       Impact factor: 4.291

4.  Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target.

Authors:  Zhenjian He; Shu An; Jiahui Chen; Shuqing Zhang; Chahui Tan; Jianchen Yu; Hengming Ye; Yun Wu; Jie Yuan; Jueheng Wu; Xun Zhu; Mengfeng Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

5.  NLRP3 Inflammasome Activation is a Prognostic Marker of Recovery in HEV-Infected Patients.

Authors:  Vikram Thakur; Radha Kanta Ratho; Mini P Singh; Yogesh Chawla; Sunil Taneja
Journal:  Curr Microbiol       Date:  2022-01-04       Impact factor: 2.188

6.  Zika virus NS5 localizes at centrosomes during cell division.

Authors:  Aditi S Kesari; Veronica J Heintz; Shishir Poudyal; Andrew S Miller; Richard J Kuhn; Douglas J LaCount
Journal:  Virology       Date:  2019-12-06       Impact factor: 3.513

Review 7.  Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases.

Authors:  Bo-Zong Shao; Qi Cao; Chong Liu
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

8.  The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus.

Authors:  Luiza A de Castro-Jorge; Renan V H de Carvalho; Taline M Klein; Carlos H Hiroki; Alexandre H Lopes; Rafaela M Guimarães; Marcílio Jorge Fumagalli; Vitor G Floriano; Mayara R Agostinho; Renata Dezengrini Slhessarenko; Fernando Silva Ramalho; Thiago M Cunha; Fernando Q Cunha; Benedito A L da Fonseca; Dario S Zamboni
Journal:  PLoS Pathog       Date:  2019-09-03       Impact factor: 6.823

9.  The liver X receptor agonist LXR 623 restricts flavivirus replication.

Authors:  Luwanika Mlera; Danielle K Offerdahl; David W Dorward; Aaron Carmody; Abhilash I Chiramel; Sonja M Best; Marshall E Bloom
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

10.  Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.

Authors:  Jie Yuan; Jianchen Yu; Yun Huang; Zhenjian He; Jia Luo; Yun Wu; Yingchun Zheng; Jueheng Wu; Xun Zhu; Haihe Wang; Mengfeng Li
Journal:  BMC Med       Date:  2020-07-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.